|
|
Progress in pharmaceutical and personal care products removal by constructal wetland |
YANG Haiyan, YANG Bo, SUN Guangdong |
Key Laboratory of Urban Storm Water System and Water Environment, Ministry of Education; Beijing University of Civil Engineering and Architecture, Beijing 100044, China |
|
|
Abstract: Pharmaceutical and personal care products(PPCPs) can be characterized by being persistent and non-degradable, and their bioaccumulation can be potentially harmful to the ecological environment. Proper and effective control of PPCPs in the sewage has become a major challenge for us. Known as an ecological wastewater treatment technology, constructed wetland is greatly concerned nowadays in the research of PPCPs removal. This paper starts with an overview which compares constructed wetland with its counterparts including wasterwater treatment plant(WWTP) and the advanced treatment (WWTP followed by UV treatment). Then it arrives at the conclusion that most of PPCPs removal efficiencies of the constructed wetland are as good as or even better than those of the conventional wasterwater treatment plants. The factors affecting the removal efficiency are analysed, and it is found that light, plants, matrix and microorganisms all contribute to the removal efficiency of PPCPs in a varying degrees. Finally, promising research directions of constructed wetland for removing PPCPs are predicted.
|
Received: 25 July 2016
|
|
|
|
[1] Pedersen J A, Yeager M A, Suffet I H. Xenobiotic organic compounds in runoff from fields irrigated with treated wastewater[J]. Journal of Agri-cultural and Food Chemistry, 2003, 51(50): 1360-1372.
[2] Brain R A, Wilson C J, Johnson D J, et al. Effects of a mixture of tetra-cyclines to Lemna gibba and Myriophyllum sibiricum evaluated in aquatic microcosms[J]. Environmental Pollution, 2005, 138(3): 425-442.
[3] Ternes T A, Meisenheimer M, McDowell D, et al. Removal of pharma-ceuticals during drinking water treatment[J]. Environmental Science & Technology, 2002, 36(17): 3855-3863.
[4] Matamoros V, Sala L, Salvadó V. Evaluation of a biologically-based fil-tration water reclamation plant for removing emerging contaminants: a pilot plant study[J]. Bioresour Technol, 2012, 104: 243-249.
[5] Ranieri E, Verlicchi P, Young T M. Paracetamol removal in subsurface flow constructed wetlands[J]. Journal of Hydrology, 2011, 404(3/4): 130-135.
[6] 程锦泉, 刘少础. 超级细菌的警示和滥用抗生素潜在公共卫生问题[J]. 中国公共卫生, 2010, 26(12): 1521-1522. Cheng Jinquan, Liu Shaochu. Superbugs warning of potential misure of antibiotics and public health problems[J]. Chinese Journal of Public Health, 2010, 26(12): 1521-1522.
[7] Daugthon C G, Ternes T A. Pharmaceuticals and personal care prod-ucts in the environment: Agent of subtable change?[J]. Environmental Health Perspectives, 1999, 107(6): 907-938.
[8] Garballa M, Omil F, Lema J M, et al. Behavior of pharmaceuticals, consmetics and hormones in a sewage treatment plant[J]. Water Re-search, 2004, 38(12): 2918-2926.
[9] Bendz D, Paxeus N A, Ginn T R, et al. Occurrence and fate of pharma-ceutically active compounds in the environment: A case study: Hoje River in Sweden[J]. Journal of Hazardous Materials, 2005, 122(3): 195-204.
[10] Heberer T. Tracking persistent pharmaceutical residues from munici-pal sewage to drinking water[J]. Journal of Hydrology, 2002, 266(3): 175-189.
[11] Ternes A T, Joss A, Siegrist H. Scrutinizing pharmaceuticals and per-sonal care products in wastewater treatment[J]. Environmental Science & Technology, 2004, 38(20): 393A-398A.
[12] Heberer T. Occurrence, fate and removal of pharmaceutical residues in the aquatic environment: A review of recent research data[J]. Toxi-cology Letters, 2002, 131(1/2): 5-17.
[13] Park N, Vanderford B J, Snyder S A. Effective controls of micropollut-ants included in wastewater effluent using constructed wetlands under anoxic condition[J]. Ecological Engineering, 2009, 35(3): 418-423.
[14] Simonich S, Federle T W, Eckhoff W S, et al. Removal of fragrance materials during U.S. and European wastewater treatment[J]. Environ-mental Science & Technology, 2002, 36(13): 2839-2847.
[15] 牛瑞华, 宋新山, 王宇晖, 等. 人工湿地对磺胺类抗生素的去除效果 及影响因素研究[D]. 上海: 东华大学, 2014. Niu Ruihua, Song Xinshan, Wang Yuhui, et al. The removal efficiency and impact factors of sulfonamides in constructed wetland[D]. Shanghai: Donghua University, 2014.
[16] 王京敏, 谢慧君. 三氯生在两种典型污水处理系统中去除的研究[D]. 山东: 山东大学, 2015. Wang Jingmin, Xie Huijun. The removal of triclosan in two typical sewage treatment system[D]. Shandong: Shandong University, 2015.
[17] Holbrook R D, Novak J T, Grizzard T J, et al. Estrogen receptor ago-nist fate during wastewater and biosolids treatment processes: A mass balance analysis[J]. Environmental Science & Technology, 2002, 36 (21): 4533-4539.
[18] Verlicchi P, Zambello E. How efficient are constructed wetlands in re-moving pharmaceuticals from untreated and treated urban wastewa-ters? A review[J]. Science of the Total Environment, 2014(470/471): 1281-1306.
[19] Matamoros V, Bayona J M. Elimination of pharmaceuticals and person-al care products in subsurface flow constructed wetlands[J]. Environ-mental Science & Technology, 2006, 40(18): 5811-5816.
[20] Matamoros V, Arias C, Brix H, et al. Removal of pharmaceuticals and personal care products (PPCPs) from urban wastewater in a pilot verti-cal flow constructed wetland and a sand filter[J]. Environmental Sci-ence & Technology, 2007, 41(23): 8171-8177.
[21] Zhang D Q, Tan S K, Gersberg R M, et al. Removal of pharmaceuti-cal compounds in tropical constructed wetlands[J]. Ecological Engi-neering, 2011, 37(3): 460-464.
[22] Le-Minh N, Khan S J, Drewes J E, et al. Fate of antibiotics during municipal water recycling treatment processes[J]. Water Research, 2010, 44(15): 4295-4323.
[23] Liu L, Liu C, Zheng J, et al. Elimination of veterinary antibiotics and antibiotic resistance genes from swine wastewater in the vertical flow constructed wetlands[J]. Chemosphere, 2013, 91(8): 1088-1093.
[24] Hijosa-Valsero M, Fink G, Schlüsener M P, et al. Removal of antibiot-ics from urban wastewater by constructed wetland optimization[J]. Che-mosphere, 2011, 83(5): 713-719.
[25] Ternes T A, Bonerz M, Herrmann N, et al. Irrigation of treated waste-water in Braunschweig, Germany: An option to remove pharmaceuti-cals and musk fragrances[J]. Chemosphere, 2007, 66(2): 894-904.
[26] Camacho-Munoz D, Martín J, Santos J L, et al. Effectiveness of con-ventional and low-cost wastewater treatments in the removal of phar-maceutically active compounds[J]. Water Air and Soil Pollution, 2012, 223(26): 11-21.
[27] Conkle J L, White J R, Metcalfe C D. Reduction of pharmaceutically active compounds by a lagoon wetland wastewater treatment system in Southeast Louisiana[J]. Chemosphere, 2008, 73(11): 1741-1748.
[28] Hijosa-Valsero M, Matamoros V, Pedescoll A, et al. Evaluation of pri-mary treatment and loading regimes in the removal of pharmaceuticals and personal care products from urban wastewaters by subsurfaceflow constructed wetlands[J]. International Journal of Environmental Analytical Chemistry, 2011, 91(7/8): 632-653.
[29] Lin A Y C, Yu T H, Lateef S K. Removal of pharmaceuticals in sec-ondary wastewater treatment processes in Taiwan[J]. Journal of Hazard-ous Materials, 2009, 167(1/3): 1163-1169.
[30] Zhang D Q, Gersberg R M, Hua T, et al. Pharmaceutical removal in tropicalsubsurface flow constructed wetlands at varying hydraulic load-ing rates[J]. Chemosphere, 2012, 87(3): 273-277.
[31] Matamoros V, Bayona J M, Salvadó V. A comparative study of remov-al of emerging pollutants in a conventional tertiary treatment and a pond-constructed wetland system[M]. Proc Venezia, 2010: 626-629.
[32] 刘小为, 陈忠林. UV/O3降解水中新兴微污染物的特性与机理研究[D]. 哈尔滨: 哈尔滨工业大学, 2012. Liu Xiaowei, Chen Zhonglin. Characteristics and mechanism for degradation of emerging micropollutants in water by UV/Ozone process[D]. Harbin: Harbin Institute of Technology, 2012.
[33] Peng X, Wang Z, Kuang W, et al. A preliminary study on the occur-rence and behavior of sulfonamides, ofloxacin and chloramphenicol an-timicrobials in wastewaters of two sewage treatment plants in Guang-zhou,China[J]. Science of the Total Environment, 2006, 371(1/3): 314-322.
[34] Roberts P H, Thomas K V. The occurrence of selected pharmaceuti-cals in wastewater effluent and surface waters of the lower Tyne catch-ment[J]. Science of the Total Environment, 2006, 356(1): 143-153.
[35] MacLeod S L, Wong C S. Loadings, trends, comparisons, and fate of achiral and chiral pharmaceuticals in wastewaters from urban tertiary and rural aerated lagoon treatments[J]. Water Research, 2010, 44(2): 533-544.
[36] Ying G, Kookana R S, Kolpin D W. Occurrence and removal of phar-maceutically active compounds in sewage treatment plants with differ-ent technologies[J]. Environ Monitor, 2009, 11(8): 1498-1505.
[37] Hijosa-Valsero M, Matamoros V, Martín-Villacorta J, et al. Assess-ment of full-scale natural systems for the removal of PPCPs from wastewater in small communities[J]. Water Research, 2010, 44(5): 1429-1439.
[38] Verlicchi P, Galletti A, Petrovic M, et al. Removal of selected pharma-ceuticals from domestic wastewater in an activated sludge system fol-lowed by a horizontal subsurface flow bed-analysis of their respective contributions[J]. Science of the Total Environment, 2013(454/455): 411-425.
[39] Breitholtz M, Näslund M, Stråe D, et al. An evaluation of free water surface wetlands as tertiary sewage water treatment of micropollutants[J]. Ecotoxicology and Environmental Safety, 2012(78): 63-71.
[40] Ge L, Chen J, Wei X, et al. Aquatic photochemistry of fluoroquinolone antibiotics: Kinetics, pathways, and multivariate effects of main water constituents[J]. Environmental Science & Technology, 2010, 44(7): 2400-2405.
[41] Boreen A L, Arnold W A, McNeill K. Photochemical fate of sulfa drugs in the aquatic environment: Sulfa drugs containing five-mem-bered heterocyclic groups[J]. Environmental Science & Technology, 2004, 38(14): 3933-3940.
[42] 周慧慧, 朱志伟. 紫外光降解水中典型羧酸类PPCPs的效能与机理[D]. 浙江: 浙江大学, 2014. Zhou Huihui, Zhu zhiwei. Photodegradation performance and mechanism of typical carboxvlic PPCPs in water by UV irradiation[D]. Zhejiang: Zhejiang University, 2014.
[43] Ávila C, Pedescoll A, Matamoros V, et al. Capacity of a horizontal sub-surface flow constructed wetland system for the removal of emerging pollutants: An injection experiment[J]. Chemosphere, 2010, 81(9): 1137-1142.
[44] Zhang D Q, Hua T, Gersberg R M, et al. Carbamazepine and naprox-en: Fate in wetland mesocosms planted with Scirpus validus[J]. Che-mosphere, 2013, 91(1): 14-21.
[45] Yamamoto H, Nakamura Y, Moriguchi S, et al. Persistence and parti-tioning of eight selected pharmaceuticals in the aquatic environment: Laboratory photolysis, biodegradation, and sorption experiments[J]. Water Research, 2009, 43(2): 351-362.
[46] Lin A, Reinhard M. Photodegradation of common environmental phar-maceuticals and estrogens in river water[J]. Environmental Toxicology and Chemistry, 2005, 24(6): 1303-1309.
[47] Anderson J C, Carlson J C, Low J E, et al. Performance of a construct-ed wetland in Grand Marais, Manitoba, Canada: Removal of nutrients, pharmaceuticals, and antibiotic resistance genes from municipal waste-water[J]. Chemistry Central Journal, 2013, 7(1): 1-15.
[48] Hussain S A, Prasher S O, Patel R M. Removal of ionophoric antibiot-ics in free water surface constructed wetlands[J]. Ecological Engineer-ing, 2012(41): 13-21.
[49] Kim I, Tanaka H. Photodegradation characteristics of PPCPs in water with UV treatment[J]. Environment International, 2009, 35(5): 793-802.
[50] Bonvin F, Omlin J, Rultler R, et al. Direct photolysis of human metab-olites of the antibiotic sulfamethoxazole: Evidence for abiotic backtransformation[ J]. Environmental Science & Technology, 2013, 47(13): 6746-6755.
[51] Hijosa-Valsero M, Matamoros V, Sidrach-Cardona R. Comprehensive assessment of the design configuration of constructed wetlandsfor the removal of pharmaceuticals and personal care products fromurban wastewaters[J]. Water Research, 2010, 44(21): 3669-3678.
[52] Zarate F M Jr, Schulwitz S E, Stevens K J, et al. Bioconcentration of triclosan, methyl-triclosan, and triclocarban in the plants and sedi-ments of a constructed wetland[J]. Chemosphere, 2012, 88(3): 323-329.
[53] 阿丹. 人工湿地对14种常用抗生素的去除效果及影响因素研究[D]. 广州: 暨南大学, 2012. Adan. The removal efficiency and impact factors of 14 antibiotics in constructed wetlands[D]. Guangzhou: Jinan University, 2012.
[54] Dordio A V, Pinto J, Dias C B, et al. Atenolol removal in microcosm constructed wetlands[J]. International Journal of Environmental Analyt-ical Chemistry, 2009, 89(8/12): 835-848.
[55] Dordio A V, Teimão J, Ramalho I, et al. Selection of a support matrix for the removal of some phenoxyacetic compounds in constructed wet-lands systems[J]. Science of the Total Environment, 2007, 380(1/3): 237-246.
[56] Li Yifei, Zhu Guibing, Wun Jern Ng, et al. A review on removing phar-maceutical contaminants from wastewater by constructed wetlands: De-sign, performance and mechanism[J]. Science of the Total Environ-ment, 2014(468/469): 908-932.
[57] Avila C, Reyes C, Bayona J M, et al. Emerging organic contaminant re-moval depending on primary treatment and operational strategy in hori-zontal subsurface flow constructed wetlands: influence of redox[J]. Wa-ter Research, 2013, 47(1): 315-325.
[58] Hussain S A, Prasher S O. Understanding the sorption of ionophoric pharmaceuticals in a treatment wetland[J]. Wetlands, 2011, 31(3): 563-571.
[59] Sassman S A, Lee L S. Sorption and degradation in soils of veterinary ionophore antibiotics: Monensin and lasalocid[J]. Environmental Toxi-cology and Chemistry, 2007, 26(8): 1614-1621.
[60] Dordio A V, Carvalho A J P. Organic xenobiotics removal in construct-ed wetlands, with emphasis on the importance of the support matrix[J]. Journal of Hazardous Materials, 2013(252/253): 272-292.
[61] Dordio A V, Duarte C, Barreiros M, et al. Toxicity and removal effi-ciency of pharmaceutical metabolite clofibric acid by Typha spp-po-tential use for phytoremediation?[J]. Bioresource Technology, 2009, 100(3): 1156-1161.
[62] Lertpaitoonpan W, Ong S K, Moorman T B. Effect of organic carbon and pH on soil sorption of sulfamethazine[J]. Chemosphere, 2009, 76 (4): 558-564.
[63] 何起利, 梁威, 贺锋, 等. 人工湿地氧化还原特征及其与微生物活性 相关性[J]. 华中农业大学学报, 2007, 26(6): 844-849. He Qili, Liang Wei, He Feng, et al. The redox characteristics and microbial activity relationships of constructed wetland[J]. Journal of Huazhong Agricultural University, 2007, 26(6): 844-849.
[64] Dua M, Singh A, Sethunathan N, et al. Biotechnology and bioremedia-tion: Successes and limitations[J]. Applied Microbiology and Biotech-nology, 2002, 59(2/3): 143-152.
[65] Seffernick J L, Wackett L P. Rapid evolution of bacterial catabolic en-zymes: A case study with atrazine chlorohydrolase[J]. Biochemistry, 2001, 40(43): 12747-12753. |
[1] |
QIU Fuguo, XU Yanqiu, XU Junting, FU Kunming. Research progress in influence factors of phosphorus removal in constructed wetland systems[J]. Science & Technology Review, 2017, 35(9): 23-29. |
[2] |
LIU Xiaohui, DONG Wenping, QIAO Guangming, WANG Yufan, WANG Weiliang. Transport-transformation, toxic effect and risk assessment of pharmaceuticals and personal care products in water[J]. Science & Technology Review, 2015, 33(16): 56-60. |
[3] |
. Use of Constructed Wetlands in Construction of Ecological City[J]. , 2005, 23(0510): 56-58. |
|
|
|
|